NMTC — Neuroone Medical Technologies Share News
0.000.00%
- $6.78m
- $4.74m
- $12.10m
U.S. STOCKS ON THE MOVE-PagerDuty, Lipella Pharma, FedEx, First Republic
U.S. STOCKS ON THE MOVE-Occidental Petroleum, Telos, Designer Brands
U.S. STOCKS ON THE MOVE-Dollar General, First Republic Bank, Qualcomm
NeuroOne up after animal implant of spine stimulator
Brief: Neuroone® Successfully Completes Initial Animal Implant Of Novel Thin Film Paddle Lead For Spinal Cord Stimulation
Brief: Neuroone® Awarded U.S. Patent Covering Novel And Proprietary Thin Film Electrode Platform
Neuroone Medical Technologies Corp reports results for the quarter ended in December - Earnings Summary
Brief: Neuroone Reports First Quarter Fiscal Year 2023 Financial Results
Neuroone Medical Technologies Corp expected to post a loss of 11 cents a share - Earnings Preview
Brief: Neuroone To Report First Quarter Fiscal Year 2023 Financial
Brief: Neuroone Medical Enters Into Capital On Demand Sales Agreement With JonesTrading
Neuroone Medical Technologies Corp expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Moderna, crypto stocks, U.S. banks
NeuroOne up on completing study of brain monitoring ablation system
Brief: NeuroOne Successfully Completes Feasibility Study With Its OneRF Ablation System
Brief: Neuroone® Ships Initial Zimmer Biomet Order For Its Evo® Seeg System For Less Than 30 Day Use
Brief: Neuroone® Receives FDA 510(K) Clearance To Market Its Evo® Seeg System For Less Than 30 Day Use
Neuroone Medical Technologies Corp reports results for the quarter ended in June - Earnings Summary
Brief: Neuroone® Reports Third Quarter Fiscal Year 2022 Financial Results And Provides Corporate Update